Exclusive interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US. He also shares thoughts on the new Trump administration and how it may impact the sector.
Exclusive interview with Timothy Taggart, CEO of American Growth Fund Series Two (AMREX), currently the only Cannabis Mutual Fund in the US. He also shares thoughts on the new Trump administration and how it may impact the sector.
Close Proponents of legalizing and regulating recreational marijuana received some good news Tuesday.
As a new market research study pegged the total value of legal North American sales of the drug in 2016 at $6.7 billion. That was a 30 percent rise over the previous year, according the report obtained by Forbes . In the U.S. alone, sales were $5.86 billion, the report found.
The largest Cannabis companies had a combined market cap of $7 Billion at the end of 2016. We're looking for the "rising tide" affect on any companies that have not enjoyed the same momentum the sector has brought to the top 10 list here.
NEWPORT BEACH, CA - December 29, 2016 Terra Tech Corp. (OTC QX: TRTC) ("Terra Tech") , a vertically integrated cannabis-focused agriculture company, today announced that its new dispensary.
It’s not just thatPot Stocks are hot, but add Cannabis Biotech's to the fire and you get explosive wealth making opportunities… Of the 10 largest MJ Stocks (by market cap) nine are biotech/pharma firms and just one “touches the plant.”
The Mainstream Growth of the Cannabidiol Market News provided by Dec 23, 2016, 09:00 NEW YORK , December 23, 2016 /PRNewswire/ -- The legal cannabis market is expanding at a rapid pace. This year five states voted to legalize cannabis for recreational use. In four of these states the proposition passed. Currently 15 states only allow Cannabidiol and alongside that, there are 28 states and District of Columbia that have legalized all forms of medical marijuana.
US scientists will treat 230 patients with the rave drug ecstasy aka MDMA MDMA is classed Class A (Schedule 1 in the US) alongside heroin and LSD It is known for giving clubbers a psychotic feeling of happiness But researchers claim it could help ease symptoms of autism or PTSD The FDA has approved large-scale clinical trials of ecstasy to treat patients with post-traumatic stress disorder.
This post Bureaucratic Incompetents And The Marijuana Boom: Who Will Win? appeared first on Daily Reckoning . On Election Day, states from sea to shining sea legalized marijuana for recreational and medical use, getting high or getting better. Now, despite pot still being federally illegal, it has become legal in 28 states.
dezembro 20, 2016 RM Consult comentários Turning High-Tech Into ‘High’ Tech: Behind Israel’s Blooming Medical Cannabis Industry Some of the recent studies coming out of Israel show that marijuana can heal bone fractures ; is able to relieve the pain associated with Parkinson’s disease; and that small quantities of cannabis can prevent brain damage , and even halt the spread of cancer .
Marijuana Industry a Homegrown Source of Job Growth The marijuana job market could double or triple in years to come. By Sean Williams On 12/17/16 at 2:00 PM Look around, and you'll struggle to find an industry hotter than marijuana. Back in 1995, not a single state had a law on its books legalizing medical cannabis or recreational pot.
Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock? By Stephen Karmazyn 15, 2016 What’s Next for Aurora Cannabis Stock? Aurora Cannabis Inc (CVE:ACB) has both reasons to be excited and reasons to be apprehensive about marijuana legalization prospects moving forward. Aurora Cannabis stock was down five percent on Wednesday, despite having gained six percent the day after the federal government’s task force released recommendations concerning the pot regulation process.
Canada will be the first major economy to fully legalize marijuana use. However, industry insiders say that’s just the starting point for the real opportunity in Canadian marijuana stocks.
Topical and transdermal product development company Skinvisible (OTCQB: SKVI) is targeting the pharmaceutical industry with its proprietary drug delivery system, Invisicare.
Is 2017 a Do-Or-Die Year for Aurora Cannabis Stock? By Stephen Karmazyn 15, 2016 What’s Next for Aurora Cannabis Stock? Aurora Cannabis Inc (CVE:ACB) has both reasons to be excited and reasons to be apprehensive about marijuana legalization prospects moving forward. Aurora Cannabis stock was down five percent on Wednesday, despite having gained six percent the day after the federal government’s task force released recommendations concerning the pot regulation process.